Rosa Sloot

1.1k total citations
18 papers, 317 citations indexed

About

Rosa Sloot is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Rosa Sloot has authored 18 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 13 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Rosa Sloot's work include HIV/AIDS Research and Interventions (8 papers), Tuberculosis Research and Epidemiology (7 papers) and HIV, Drug Use, Sexual Risk (4 papers). Rosa Sloot is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), Tuberculosis Research and Epidemiology (7 papers) and HIV, Drug Use, Sexual Risk (4 papers). Rosa Sloot collaborates with scholars based in South Africa, United Kingdom and Netherlands. Rosa Sloot's co-authors include Martien W. Borgdorff, Maarten F. Schim van der Loeff, P. M. Kouw, Philip Supply, Dick van Soolingen, Jakko van Ingen, Sue‐Ann Meehan, Pren Naidoo, Nulda Beyers and Heather R. Draper and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Journal of Clinical Microbiology.

In The Last Decade

Rosa Sloot

16 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Sloot South Africa 8 283 235 113 26 23 18 317
Wilbert Bara Zimbabwe 6 401 1.4× 326 1.4× 147 1.3× 10 0.4× 17 0.7× 6 436
Joseph S. Cavanaugh United States 14 450 1.6× 359 1.5× 185 1.6× 17 0.7× 14 0.6× 33 508
Olive Mbabazi Uganda 9 242 0.9× 215 0.9× 103 0.9× 8 0.3× 11 0.5× 13 322
Basra Doulla Tanzania 11 201 0.7× 179 0.8× 51 0.5× 13 0.5× 30 1.3× 18 282
Odelia Muller South Africa 9 280 1.0× 258 1.1× 92 0.8× 16 0.6× 10 0.4× 14 366
Dima Kabbani Canada 10 165 0.6× 209 0.9× 33 0.3× 25 1.0× 8 0.3× 39 323
Khardiata Diallo Mbaye Senegal 5 105 0.4× 120 0.5× 30 0.3× 13 0.5× 22 1.0× 19 228
Mahmud Hanif India 12 501 1.8× 387 1.6× 209 1.8× 13 0.5× 22 1.0× 35 565
Elena Ivanova Reipold Switzerland 11 240 0.8× 276 1.2× 58 0.5× 7 0.3× 8 0.3× 32 432
Vera Simonsen Brazil 9 149 0.5× 164 0.7× 44 0.4× 15 0.6× 26 1.1× 19 259

Countries citing papers authored by Rosa Sloot

Since Specialization
Citations

This map shows the geographic impact of Rosa Sloot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Sloot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Sloot more than expected).

Fields of papers citing papers by Rosa Sloot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Sloot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Sloot. The network helps show where Rosa Sloot may publish in the future.

Co-authorship network of co-authors of Rosa Sloot

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Sloot. A scholar is included among the top collaborators of Rosa Sloot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Sloot. Rosa Sloot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Majuelos‐Melguizo, Jara, et al.. (2025). Mortality Risk Among Patients With Influenza Illness Admitted to the ICU: A Systematic Review and Meta‐Analysis. Influenza and Other Respiratory Viruses. 19(3). e70073–e70073.
2.
Sloot, Rosa, Alexander Breskin, Lisandro D. Colantonio, et al.. (2024). Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study. Epidemiology. 35(4). 579–588.
3.
Wilson, Ethan, Rosa Sloot, Justin Bwalya, et al.. (2023). Predictors of participant retention in a community-based HIV prevention cohort: perspectives from the HPTN 071 (PopART) study. Trials. 24(1). 434–434. 3 indexed citations
4.
Yang, Blia, Rosa Sloot, Sian Floyd, et al.. (2023). Brief Report: How Do We Reach Men? Offering HIV Testing in Evenings and Weekends in the HPTN 071 (PopART) Community-Based Trial in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 93(4). 300–304. 1 indexed citations
5.
Sloot, Rosa, Olisaeloka Nsonwu, Dimple Chudasama, et al.. (2021). Rising rates of hospital-onset Klebsiella spp. and Pseudomonas aeruginosa bacteraemia in NHS acute trusts in England: a review of national surveillance data, August 2020–February 2021. Journal of Hospital Infection. 119. 175–181. 17 indexed citations
6.
Sloot, Rosa, Gerald J. Maarman, Sam Griffith, et al.. (2021). Improving retention of community-recruited participants in HIV prevention research through Saturday household visits; findings from the HPTN 071 (PopART) study in South Africa. BMC Medical Research Methodology. 21(1). 242–242. 3 indexed citations
7.
Sloot, Rosa, Karen Du Preez, Alexander Kay, et al.. (2021). The Magnitude of Interferon Gamma Release Assay Responses in Children With Household Tuberculosis Contact Is Associated With Tuberculosis Exposure and Disease Status. The Pediatric Infectious Disease Journal. 40(8). 763–770. 4 indexed citations
8.
9.
Sloot, Rosa, Kwame Shanaube, Mareli Claassens, et al.. (2020). Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa. BMC Infectious Diseases. 20(1). 760–760. 3 indexed citations
12.
Meehan, Sue‐Ann, Rosa Sloot, Heather R. Draper, et al.. (2018). Factors associated with linkage to HIV care and TB treatment at community-based HIV testing services in Cape Town, South Africa. PLoS ONE. 13(4). e0195208–e0195208. 22 indexed citations
13.
Rossouw, Laura, et al.. (2017). Access to human immunodeficiency virus testing services in Cape Town, South Africa: a user perspective. Public Health Action. 7(4). 251–257. 1 indexed citations
14.
Sloot, Rosa, Maarten F. Schim van der Loeff, P. M. Kouw, & Martien W. Borgdorff. (2014). Risk of Tuberculosis after Recent Exposure. A 10-Year Follow-up Study of Contacts in Amsterdam. American Journal of Respiratory and Critical Care Medicine. 190(9). 1044–1052. 132 indexed citations
15.
Sloot, Rosa, Maarten F. Schim van der Loeff, P. M. Kouw, & Martien W. Borgdorff. (2014). Yield of tuberculosis contact investigations in Amsterdam: opportunities for improvement. European Respiratory Journal. 44(3). 714–724. 14 indexed citations
16.
Sloot, Rosa, Maarten F. Schim van der Loeff, Erik W. van Zwet, et al.. (2014). Biomarkers Can Identify Pulmonary Tuberculosis in HIV-infected Drug Users Months Prior to Clinical Diagnosis. EBioMedicine. 2(2). 172–179. 28 indexed citations
17.
Ingen, Jakko van, Gèrard de Vries, Connie Erkens, et al.. (2013). Comparative Study of IS 6110 Restriction Fragment Length Polymorphism and Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Isolates in the Netherlands, Based on a 5-Year Nationwide Survey. Journal of Clinical Microbiology. 51(4). 1193–1198. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026